SCHEMBL5043889

SCHEMBL5043889

CCC(C)NC(=O)Oc1cc(-c2csc(-c3ccc(OC)cc3)n2)n(CC2CCCCC2)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25A P30304 2/20 0.43
CDC25B P30305 2/20 0.43
CDC25C P30307 2/20 0.43
DUSP3 P51452 2/20 0.43
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KCNQ1 P51787 7/20 0.38
MAPK1 P28482 2/20 0.37
HSD17B10 Q99714 2/20 0.37
TP53 P04637 1/20 0.37
STAT1 P42224 1/20 0.37
OXTR P30559 1/20 0.37
AVPR1A P37288 1/20 0.37
AVPR1B P47901 1/20 0.37
FAAH O00519 1/20 0.36
HPGD P15428 2/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5048642 0.89 CDC25A (0.44) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5047175 0.88 PPARD (0.39) NPC1RAB9AKCNQ1PLA2G2APOLB
SCHEMBL5044983 0.88 CDC25A (0.44) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5140692 0.88 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5039914 0.88 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5043910 0.88 CDC25A (0.45) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5039564 0.87 FAAH (0.46) CDC25ACDC25BCDC25CDUSP3ALDH1A1
SCHEMBL5048696 0.87 CDC25A (0.43) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5043836 0.86 CDC25A (0.46) CDC25ACDC25BCDC25CDUSP3NPC1
SCHEMBL5044042 0.86 CDC25A (0.42) CDC25ACDC25BCDC25CDUSP3NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583762-B1 PYRROLYL-THIAZOLES AND THEIR USE AS CB 1 RECEPTOR INVERSE AGONISTS HOFFMANN LA ROCHE (CH) 2008-07-09 EP claimed